BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25895667)

  • 1. Translocation t(11;19)(q23;q13.1) without MLL Rearrangement in Acute Myeloid Leukemia: Heterogeneity of the 11q23 Breakpoints.
    Yamamoto K; Kawamoto S; Kakiuchi S; Yakushijin K; Matsuoka H; Minami H
    Acta Haematol; 2015; 134(2):76-9. PubMed ID: 25895667
    [No Abstract]   [Full Text] [Related]  

  • 2. MLL-SEPT5 fusion transcript in infant acute myeloid leukemia with t(11;22)(q23;q11).
    Launay E; Henry C; Meyer C; Chappé C; Taque S; Boulland ML; Ben Abdelali R; Dugay F; Marschalek R; Bastard C; Fest T; Gandemer V; Belaud-Rotureau MA
    Leuk Lymphoma; 2014 Mar; 55(3):662-7. PubMed ID: 23725386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
    He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21).
    Wang Y; Li W; Chen S; Qiu H; Sun A; Wu D
    Leuk Res; 2011 May; 35(5):604-7. PubMed ID: 21130493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia.
    Gozzetti A; Calabrese S; Raspadori D; Crupi R; Tassi M; Bocchia M; Fabbri A; Lauria F
    Cancer Genet Cytogenet; 2007 Aug; 177(1):81-2. PubMed ID: 17693199
    [No Abstract]   [Full Text] [Related]  

  • 6. Translocation t(1;11)(q21;q23): a new finding in congenital acute myeloid leukemia.
    Reynaert N; Vandenberghe P; Boeckx N; Renard M; Uyttebroeck A; Labarque V
    Leuk Lymphoma; 2014 Jun; 55(6):1435-6. PubMed ID: 24001130
    [No Abstract]   [Full Text] [Related]  

  • 7. A cryptic three-way translocation t(10;19;11)(p12.31;q13.31;q23.3) with a derivative Y-chromosome in an infant with acute myeloblastic leukemia (M5b).
    Othman MA; Vujić D; Zecević Z; Đurišić M; Slavković B; Meyer B; Liehr T
    Gene; 2015 Jun; 563(2):115-9. PubMed ID: 25725124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia].
    Chen L; Wei XD; Yin QS
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):484-6. PubMed ID: 22967387
    [No Abstract]   [Full Text] [Related]  

  • 9. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Snijder S; Mellink CH; van der Lelie H
    Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical outcome of CAG regimen in 26 children with aucte myeloid leukemia].
    Chen X; Ruan M; Liu F; Liu TF; Chen XJ; Guo Y; Zhang L; Yang WY; Chang LX; Zhao BB; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):594-596. PubMed ID: 32397024
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy analysis of CAG priming regimen combined with talidomide, interferon and interleukin 2 as the induction therapy for relapsed refractory acute myeloid leukemia].
    Zu Y; Zhang Y; Zhou J; Zhao H; Gui R; Li Z; Li M; Wei X; Song Y
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):334-6. PubMed ID: 27093999
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute myeloblastic leukemia in a patient with hereditary protein C deficiency.
    Matsui K; Tanaka Y; Yamashita K; Matsuda K; Shinohara K
    Intern Med; 2006; 45(11):729-32. PubMed ID: 16819254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel variant form of t(11;22)(q23;q13)/MLL-EP300 fusion transcript in the evolution of an acute myeloid leukemia with myelodysplasia-related changes.
    Duhoux FP; De Wilde S; Ameye G; Bahloula K; Medves S; Légé G; Libouton JM; Demoulin JB; A Poirel H
    Leuk Res; 2011 Mar; 35(3):e18-20. PubMed ID: 20980053
    [No Abstract]   [Full Text] [Related]  

  • 14. De novo acute myeloblastic leukemia with trilineage abnormalities and a t(3;12) in a child.
    Hazard E; Bastard C; Callat MP; Schneider P; Vannier JP
    Med Pediatr Oncol; 2003 Jun; 40(6):397-400. PubMed ID: 12692813
    [No Abstract]   [Full Text] [Related]  

  • 15. [Curative effect of low dose cytarabine and aclarubin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on patients with the intermediate and high-risk myelodysplastic syndrome].
    Zhu Y; He Y; Chen S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 35(4):370-3. PubMed ID: 20448361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new chromosomal three-way rearrangement involving MLL masked by a t(9;19)(p11;p13) in an infant with acute myeloid leukemia.
    de Jesus Marques-Salles T; Liehr T; Mkrtchyan H; Raimondi SC; Tavares de Souza M; de Figueiredo AF; Rouxinol S; Jordy Macedo FC; Abdelhay E; Santos N; Macedo Silva ML
    Cancer Genet Cytogenet; 2009 Feb; 189(1):59-62. PubMed ID: 19167614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia.
    Lu H; Lu SF; Shen WY; Hong M; Zhang JF; Wang LX; Yang H; Li JY
    Leuk Res; 2008 Nov; 32(11):1776-9. PubMed ID: 18501425
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of FLAG as initial induction chemotherapy followed by autologous hematopoietic stem cell transplantation after IBu conditioning regimen in acute myeloid leukemia with FLT3 mutations].
    Wang B; Yang B; Dong W; Liu D; Ling Y; Cao X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):653-5. PubMed ID: 25052613
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation.
    Chen SS; Sun Q; Cao L; Wu WZ; Xie Y; Qiao C; Li JY; Qian SX; Hong M
    Chin Med J (Engl); 2020 Dec; 134(12):1477-1479. PubMed ID: 33323826
    [No Abstract]   [Full Text] [Related]  

  • 20. Translocation between chromosome 5q35 and chromosome 11q13-- an unusual cytogenetic finding in a primary refractory acute myeloid leukemia.
    Wang TF; Horsley SW; Lee KF; Chu SC; Li CC; Kao RH
    Clin Lab Haematol; 2006 Jun; 28(3):160-3. PubMed ID: 16706931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.